Title |
AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant LeukemiaAXL Blockade Elicits Antileukemic Immunity and PD-1 Blockade
|
---|---|
Published in |
Cancer Discovery, June 2021
|
DOI | 10.1158/2159-8290.cd-20-1378 |
Pubmed ID | |
Authors |
Irene Tirado-Gonzalez, Arnaud Descot, Devona Soetopo, Aleksandra Nevmerzhitskaya, Alexander Schäffer, Ivan-Maximilano Kur, Ewelina Czlonka, Carolin Wachtel, Ioanna Tsoukala, Luise Müller, Anna-Lena Schäfer, Maresa Weitmann, Petra Dinse, Emily Alberto, Michèle C. Buck, Jonathan JM. Landry, Bianka Baying, Julia Slotta-Huspenina, Jenny Roesler, Patrick N. Harter, Anne-Sophie Kubasch, Jörn Meinel, Eiman Elwakeel, Elisabeth Strack, Christine Tran Quang, Omar Abdel-Wahab, Marc Schmitz, Andreas Weigert, Tobias Schmid, Uwe Platzbecker, Vladimir Benes, Jacques Ghysdael, Halvard Bonig, Katharina S. Götze, Carla V. Rothlin, Sourav Ghosh, Hind Medyouf |
X Demographics
The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 14 | 29% |
Germany | 12 | 24% |
Spain | 1 | 2% |
Hong Kong | 1 | 2% |
India | 1 | 2% |
France | 1 | 2% |
Singapore | 1 | 2% |
Unknown | 18 | 37% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 29 | 59% |
Scientists | 13 | 27% |
Science communicators (journalists, bloggers, editors) | 5 | 10% |
Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 35 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 20% |
Student > Ph. D. Student | 3 | 9% |
Student > Doctoral Student | 3 | 9% |
Other | 2 | 6% |
Professor > Associate Professor | 2 | 6% |
Other | 6 | 17% |
Unknown | 12 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 17% |
Biochemistry, Genetics and Molecular Biology | 5 | 14% |
Agricultural and Biological Sciences | 2 | 6% |
Immunology and Microbiology | 2 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 4 | 11% |
Unknown | 15 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2023.
All research outputs
#1,298,993
of 25,711,998 outputs
Outputs from Cancer Discovery
#667
of 4,148 outputs
Outputs of similar age
#33,348
of 460,457 outputs
Outputs of similar age from Cancer Discovery
#28
of 107 outputs
Altmetric has tracked 25,711,998 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,148 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,457 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.